Febuxostat 144060-53-7 Adenuric
USP2010 Top Quality Febuxostat
CAS.No.: 144060-53-7
Appearance: Off- white to white crystalline powder
Product Name: | Febuxostat |
Synonyms : | 2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid; 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid; 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid; Febuxostat (Polymorphs); 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid |
EINECS : | NA |
Grade Standard : | Medicine Grade |
Specification: | 99% |
Appearance: | Off- white to white crystalline powder |
Standard : | Enterprise Standard |
CAS.No.: | 144060-53-7 |
Fomular Structure: | |
Usage: | Medicine |
Storage: |
Stored in cool & dry place Kept away from strong light and heat |
Shelf Life: | 2 years when properly stored |
Application
Febuxostat (INN; trade names Adenuric [EU], Febutaz [India] and Uloric [US]) is a urate lowering drug, an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and chronic gout.
Febuxostat received marketing approval by the European Medicines Agency on April 21, 2008 and was approved by the U.S. Food and Drug Administration on February 16, 2009.
A study comparing febuxostat to allopurinol found that more individuals treated with febuxostat had decreased levels of uric acid, but there was no difference in the amount of initial gout flares or the surface area of gout tophi.
Our Factory
Quality control
Shipment
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View